PATENT CLAIM ANALYSIS

Application Number: 15963535
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "210200"]

Abstract:
The present invention provides compounds of formula (I) which inhibit the activity of PI 3-kinase gamma isoform, which are useful for the treatment of diseases mediated by the activation of PI 3-kinase gamma isoform.

Claim (Index 6):
The compound according to  claim 1  of formula (I) wherein E is selected from N and CR E ; R 1 , R 2  and R E  are independently selected from H, halogen, C 1-4  alkyl, C 1-4  alkoxy, C 1-4  haloalkyl, C 1-4  haloalkoxy, C 1-4  hydroxyalkyl and C 3-7  cycloalkyl; Y is selected from the group consisting of R 4  is H and R 3  is selected from the group consisting of or R 3  and R 4  together with the nitrogen atom to which they are attached form a C 3-7  heterocyclyl selected from the group consisting of or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15303879', '15303868', '15303890', '12765904', '15736450']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8442749712293561
- 35 USC 102 Novelty (BERT): 0.6086052780511008
- Combined Prediction Score: 0.8207080019115306
- Mean Citation Score: 436.623092
- Max Citation Score: 539.0702
- Similarity Product: 514.9869536451698

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test